Abstrakt

Cystic fibrosis is a so-far incurable multiorgan disease. Therapies are improving, and thus the percentage of adult patients has doubled over the past 20 years and is expected to increase even further. The current patientcare settings are not adequate for this situation, particularly because during adolescence there is an increased risk of comorbidities and adherence to time-consuming therapies might become bad. Approaches for the transition from pediatric to adult healthcare are scarce; however, some research on the adolescents‘ ideas of how the disease should be handled and treated has been made. Currently, transition to adult care seems to work best in combined centers of pediatric and internal medicine, where a high grade of experience exists within a large multidisciplinary expert team.

Autoreninformation

Autoren

• D. Staab¹
• C. Lehmann¹
• J. Schmidt²
• C. Schwarz¹

Abteilungen

• ¹ Klinik für Pädiatrische Pneumologie und Immunologie, Christiane Herzog-Zentrum, Charité – Universitätsmedizin Berlin,
• ² Klinik für Kinder- und Jugendmedizin, Universität zu Lübeck

Adresse

PD Dr. med. Doris Staab
Klinik für Pädiatrische Pneumologie und Immunologie
Christiane Herzog-Zentrum
Charité – Universitätsmedizin Berlin
Augustenburger Platz 1
13353 Berlin
Email: [email protected]

Citation